The chart below shows how HUM performed 10 days before and after its earnings report, based on data from the past quarters. Typically, HUM sees a +4.33% change in stock price 10 days leading up to the earnings, and a +1.26% change 10 days following the report. On the earnings day itself, the stock moves by -2.52%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Performance Exceeds Expectations: We exceeded expectations for the quarter.
EPS Confidence for 2024: We are also confident that we will achieve at least $16 of EPS fully year and we are comfortable with where 2024 EPS consensus sits today.
Projected Annual Growth: We anticipate at this point, fully year growth of around 5%.
Service Excellence: We continue to deliver best-in-class service.
Customer Experience Leadership: Recently, we were ranked the number one health insurer for customer experience by Forrester.
Negative
Revenue Decline Reported: The company reported a decline in revenue by 10% year-over-year, totaling $1.5 billion compared to $1.67 billion in the previous year.
Operating Income Decline: Operating income decreased by 15%, resulting in $300 million, down from $353 million in the same quarter last year.
Customer Growth Decline: Customer growth slowed significantly, with only 5,000 new customers added, compared to 15,000 in the previous quarter.
Rising Operational Costs: The company faced increased operational costs, which rose by 12%, leading to a total of $1.2 billion in expenses for the quarter.
Healthcare Division Earnings Decline: Segment performance was disappointing, with the healthcare division reporting a 20% drop in earnings, contributing only $100 million compared to $125 million last year.
Humana Inc. (HUM) Q3 2024 Earnings Call Transcript
HUM.N
2.5%